Page 5 - Testosterone Suppression News Today

Media theyll end up the target of a twitter woke mob or people inside their own companies will come after them that we dont actually end up having a real debate. this is a man who was a really talented swimmer for three years, same school, switches genders and now is dominating the women really need to speak out and tell their story. i bet many of them are afraid to say anything. >> dana: i think some womens sports professionals have spoken out, right, and they do get the mob coming after them. ...

Evolutionary biologist Colin Wright has been censored by Instagram after posting a chart from a respected scientific journal illustrating how men are biologically stronger than women at a variety [...]

The best uncensored news, information, and analysis.

Neon Nettle - Instagram Censors Renowned Biologist for Noting Men Are Stronger than Women - Top academic has post taken down for hate speech for sharing peer-reviewed study

This is what anti-science looks like

The deadline for weightlifters to qualify for the delayed Tokyo 2020 Olympic Games is upon us and there is no doubt about who, among the qualifiers, wins the gold medal for attracting publicity.

Fri Feb 5, 2021 The Left’s thought police at DePaul University in Chicago have come after Dr. Jason D. Hill, a tenured professor of philosophy and a Shillman Journalism Fellow at the David Horowitz Freedom Center. The leftwing fascists treat every expression of views they don’t like on a controversial issue as evidence of bigotry against one or another so-called “oppressed” minority. The censors demand conformity or punishment for dissenting views. In Dr. Hill’s case, one ...

SUO 2020: Debate: Relugolix for Advanced Prostate Cancer is the New Standard (The HERO Study) (UroToday.com) During the second prostate cancer session at the 2020 Annual Meeting of the Society of Urologic Oncology (SUO), Drs. Neal Shore and Ashley Evan Ross debated the use of relugolix as a new standard of care for androgen deprivation therapy (ADT) for the treatment of prostate cancer. This debate follows the publication of the HERO trial, 1  A Study to Evaluate the Safety and Efficacy of Re...